New Drug Applications Liquidia Announces FDA Acceptance of New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension 5 years ago
Pharma Industry News Novartis to begin trial of hydroxychloroquine treatment for COVID-19 5 years ago
Pharma Industry News Seattle Genetics gets US approval for oral HER2 breast cancer drug Tukysa 5 years ago
Healthcare News COVID-19 Cases: At Least 200,000 May Have Been Infected With Coronavirus In LA County 5 years ago